For localization of recurrence, we performed a prostate-specific membrane antigen (PSMA)-targeted positron emission tomography–computed tomography (PET/CT) using [68Ga]Ga-PSMA-11, which is an established imaging modality in the management of prostate cancer [1,2,3]. Here, FOLH1 is linked to prostate cancer.